Impel Neuropharma Inc reports results for the quarter ended in September - Earnings Summary

IPI Legacy Liquidation Co

15/11/2021 20:30

* Impel Neuropharma Inc  IMPL.OQ  reported a quarterly adjusted
loss of $1.24​​ per share for the quarter ended in September.
The mean expectation of two analysts for the quarter was for a
loss of 75 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Impel Neuropharma Inc's reported EPS for the quarter was a
loss of $1.24​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Impel Neuropharma Inc shares had fallen by 5.5% this quarter.
* The company reported a quarterly loss of $25.02 million.
* Wall Street's median 12-month price target for Impel
Neuropharma Inc is $50.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated November 15 at 08:30 p.m.
 ​All figures in US dollars unless otherwise stated